F. Brégier, S. Karuppannan, J.-C. Chambron
FULL PAPER
As TLC analysis indicated the presence of remaining starting mate-
rial as well as the mono- and disubstituted derivatives, another por-
tion of sodium hydride (60% w/w in oil, 0.143 g, 3.58 mmol) was
added followed by the addition of 5 (1.378 g, 3.51 mmol) 1 h later
and the mixture was stirred for 22 h at room temperature. The same
procedure was repeated once with sodium hydride (60% w/w in oil,
0.161 g, 4.03 mmol) and 5 (0.365 g, 0.931 mmol). The reaction was
stirred for a further 24 h. The solvent was then evaporated under
reduced pressure and the residue was extracted with CH2Cl2. The
organic layer was washed with water, brine and dried with magne-
sium sulfate. After evaporating the solvent under reduced pressure
the crude product was purified by column chromatography on silica
gel (MeOH/CH2Cl2, gradient from 6:94 to 1:9) to afford compound
6 as a colourless solid (0.285 g, 0.144 mmol) in 49% yield. 1H
NMR (500 MHz, CDCl3, 300 K): δ = 6.89 (s, 3 H, βЈ-H), 6.86 (s,
6 H, αЈ-H, α-H), 5.07 (d, JH,H = 3.0 Hz, 3 H, 1- or 1Ј-H), 5.04 (d,
JH,H = 3.3 Hz, 3 H, 1- or 1Ј-H), 4.70 [d, JH,H = 11.7 Hz, 3 H,
traces of formic acid. The solvent was then evaporated under re-
duced pressure and the residue purified twice by column
chromatography on silica gel (MeOH/CH2Cl2, 3:97) to provide first
intermediate 7 as a mixture of diastereomers 7a and 7b (0.169 g,
49%) followed by cavitand 1 as a colourless solid (23.2ϫ10–3 g,
1.39ϫ10–2 mmol) in 8% yield.
Procedure B: A solution of precursor 6 (0.300 g, 0.152 mmol) in
CH2Cl2 (20 mL) was added to a stirred suspension of scandium
triflate (0.076 g, 0.154 mmol) in CH2Cl2 (38 mL) at reflux over a
period of 25–30 h through a syringe pump. After complete ad-
dition, the reaction mixture was stirred at 40 °C for a further 48 h.
The dark solution was then poured into water and extracted three
times with CH2Cl2. The combined organic layers were washed with
brine and dried with magnesium sulfate. After evaporating the sol-
vent under reduced pressure the crude product was purified by col-
umn chromatography on silica gel (MeOH/CH2Cl2, 3:97) to afford
cavitand 1 as a colourless solid (12.7ϫ10–3 g, 7.61ϫ10–3 mmol) in
ArCH2(A)], 4.67 (t, JH,H = 3.6 Hz, 3 H, 9-H), 4.42 [d, JH,H
11.7 Hz, 3 H, ArCH2(B)], 4.16 (m, 6 H, 8A/B-H), 4.10 (dd, JH,H
=
=
1
5% yield. H NMR (600 MHz, [D6]acetone, 300 K): δ = 7.13 (s, 3
H, α-H), 7.09 (s, 3 H, αЈ-H), 4.97 (d, JH,H = 3.3 Hz, 6 H, 1/1Ј-H),
4.78 (d, JH,H = 13.5 Hz, 3 H, Ha), 4.20 (ddd, JH,H = 11.4, 5.0,
4.5 Hz, 3 H, 8A-H), 4.13 (ddd, JH,H = 11.4, 7.2, 4.1 Hz, 3 H, 8B-
H), 3.87 (ddd, JH,H = 11.9, 7.0, 4.0 Hz, 3 H, 7A-H), 3.84 (s, 9 H,
OCH3-Ar), 3.77 (dd, JH,H = 11.7, 4.1 Hz, 3 H, 6ЈA-H), 3.67 (dd,
JH,H = 10.4, 1.4 Hz, 3 H, 6A-H), 3.64–3.56 (m, 12 H, 7B-H, He,
5/5Ј-H), 3.55 (s, 9 H, 3- or 3Ј-OCH3), 3.55 (s, 9 H, 3- or 3Ј-OCH3),
3.50 (dd, JH,H = 10.4, 1.4 Hz, 3 H, 6B-H), 3.48–3.46 (m, 3 H, 4-
or 4Ј-H), 3.45 (s, 9 H, 2- or 2Ј-OCH3), 3.44 (s, 9 H, 2- or 2Ј-OCH3),
3.43–3.40 (m, 6 H, 4- or 4Ј-H, 6ЈB-H), 3.37 (td, JH,H = 4.4, 8.9 Hz,
6 H, 3/3Ј-H), 3.09 (s, 9 H, 6Ј-OCH3), 3.02 (dd, JH,H = 5.3, 3.3 Hz,
3 H, 2- or 2Ј-H), 3.00 (dd, JH,H = 5.2, 3.3 Hz, 3 H, 2- or 2Ј-H) ppm.
13C NMR (150 MHz, [D6]acetone, 300 K): δ = 149.6 (C-γ), 147.7
(C-γЈ), 134.1 (C-β), 133.0 (C-βЈ), 117.6 (C-αЈ), 114.8 (C-α), 100.4,
100.2 (C-1/1Ј), 83.6 (C-4 or -4Ј), 83.38, 83.36 (C-2/2Ј), 82.9 (C-4
or -4Ј), 82.34, 82.26 (C-3/3Ј), 72.4, 72.3 (C-5/5Ј), 71.8 (C-6Ј), 70.8
(C-6), 69.3 (C-8), 69.1 (C-7), 61.79, 61.76 (3/3Ј-OCH3), 58.8 (6Ј-
OCH3), 58.0, 57.9 (2/2Ј-OCH3), 56.5 (OCH3-Ar), 36.4
(ArCH2) ppm. HRMS (ESI): calcd. for C81H120NaO36 [M + Na]+
1691.74515; found 1691.74451.
10.8, 3.1 Hz, 3 H, 6A-H), 3.90 (m, 9 H, 13A-H, 7A/B-H), 3.83 (s,
9 H, OCH3-Ar), 3.82–3.67 (m, 21 H, 6B-H, 6ЈA/B-H, 5/5Ј-H, 4/4Ј-
H), 3.64 (s, 9 H, 3- or 3Ј-OCH3), 3.62 (s, 9 H, 3- or 3Ј-OCH3), 3.53
(m, 9 H, 13B-H, 3/3Ј-H), 3.48 (s, 9 H, 2- or 2Ј-OCH3), 3.43 (s, 9
H, 2- or 2Ј-OCH3), 3.33 (s, 9 H, 6Ј-OCH3), 3.15 (dd, JH,H = 10.0,
3.3 Hz, 3 H, 2- or 2Ј-H), 3.11 (dd, JH,H = 9.2, 3.0 Hz, 3 H, 2- or
2Ј-H), 1.85 (m, 3 H, 10A-H), 1.72 (m, 3 H, 11A-H), 1.58 (m, 12 H,
1
10B-H, 11B-H, 12A/B-H) ppm. H NMR (600 MHz, [D6]acetone,
300 K): δ = 6.97 (d, JH,H = 1.9 Hz, 3 H, α-H), 6.94 (d, JH,H
=
8.2 Hz, 3 H, αЈ-H), 6.87 (m, 3 H, βЈ-H), 5.07 (d, JH,H = 3.2 Hz, 3
H, 1-H), 4.99 (d, JH,H = 3.4 Hz, 3 H, 1Ј-H), 4.66 (t, JH,H = 3.4 Hz,
3 H, 9-H), 4.64 [d, JH,H = 11.7 Hz, 3 H, ArCH2(A)], 4.40 [d, JH,H
= 11.7 Hz, 3 H, ArCH2(B)], 4.20–4.15 (m, 6 H, 8A-H, 7A-H), 4.13–
4.09 (m, 3 H, 8B-H), 3.91–3.79 (m, 15 H, 13A-H, 6A/B-H, 5/5-HЈ),
3.83 (s, 9 H, OCH3-Ar), 3.74–3.67 (m, 12 H, 7B-H, 6ЈA/B-H, 4Ј-
H), 3.58 (s, 9 H, 3- or 3Ј-OCH3), 3.56 (s, 9 H, 3- or 3Ј-OCH3), 3.48
(m, 3 H, 13B-H), 3.46 (s, 9 H, 2- or 2Ј-OCH3), 3.405 and 3.403 (2
s, 9 H, 2- or 2Ј-OCH3), 3.40 (m, 9 H, 3/3Ј-H, 4-H), 3.31 (s, 9 H,
6Ј-OCH3), 3.04 (dd, JH,H = 9.9, 3.4 Hz, 3 H, 2Ј-H), 2.99 (m, 3 H,
2-H), 1.81 (m, 3 H, 11A-H), 1.67 (m, 3 H, 10A-H), 1.52 (m, 12 H,
10B-H, 11B-H, 12A/B-H) ppm. 13C NMR (150 MHz, [D6]acetone,
300 K): δ = 150.61, 150.60 (C-γ), 149.11 (C-γЈ), 132.51, 132.50 (C-
β), 121.13, 121.12 (C-βЈ), 114.56, 114.54 (C-αЈ), 113.31, 113.28 (C-
α), 100.44 (C-1Ј), 99.74, 99.73 (C-1), 98.09, 98.08 (C-9), 83.32 (C-
4), 83.17, 83.12 (C-2/2Ј), 82.56 (C-4Ј), 82.51, 82.48 (C-3/3Ј), 72.76
(C-6Ј), 72.27 (C-5Ј), 71.79 (C-5), 70.52, 70.51 (C-7), 70.41 (C-6),
69.13, 69.10 (C-8), 69.07, 69.06 (ArCH2), 62.29, 62.28 (C-13),
61.82, 61.72 (3/3Ј-OCH3), 58.90 (6Ј-OCH3), 58.20, 57.82 (2Ј-
OCH3), 57.81 (2-OCH3), 56.36 (OCH3-Ar), 31.37 (C-10), 26.31 (C-
12), 20.10 (C-11) ppm. HRMS (ESI): calcd. for C96H150NaO42 [M
+ Na]+ 1997.94939; found 1997.95692.
MALDI-TOF MS Studies: Formic acid (10 mL) was added in one
portion to a solution of precursor 6 (0.042 g, 0.0213 mmol) in chlo-
roform (10 mL) under nitrogen. Aliquots (0.1 mL) were withdrawn
from time to time, neutralized with NaHCO3 and extracted into
dichloromethane (see Figures S26 and S27 in the Supporting Infor-
mation).
Supporting Information (see footnote on the first page of this arti-
cle): 1H and 13C NMR spectra of compounds 1, 3 and 6. 1H NMR
1
spectrum of compound 7. 1H–1H COSY and ROESY, and H–13C
HSQC and HMBC NMR spectra of compounds 1 and 6. ESI-
HRMS spectra of compounds 1, 3, 6 and 7. MALDI-TOF and
1H NMR spectra recorded during the formation of compound 1
(procedure A).
Compound 7: See the preparation of cavitand 1 below. Characteri-
zation: HRMS (ESI): calcd. for C83H124NaO40 [M
+
Na]+
1783.75611; found 1783.76066. 1H NMR (600 MHz, [D6]acetone,
300 K): see the Supporting Information.
Acknowledgments
Synthesis of Cavitand 1
The Conseil Régional de Bourgogne is acknowledged for post-doc-
toral fellowships to F. B. and S. K. (PARI IME SMT 8 program),
and Marie-José Penouilh is thanked for the ESI-HRMS spectra.
Procedure A: Formic acid (92 mL) was added in one portion to a
solution of precursor 6 (0.386 g, 0.195 mmol) in chloroform
(92 mL) under nitrogen. The reaction mixture was gently stirred at
55 °C and monitored by 1H NMR and MALDI-TOF MS. After
16 h, the reaction was quenched with a saturated aqueous solution
of NaHCO3 and extracted into CH2Cl2. The organic phase was
washed with a saturated aqueous solution of NaHCO3 to remove
[1] a) J. R. Moran, S. Karbach, D. J. Cram, J. Am. Chem. Soc.
1982, 104, 5826–5828; b) D. J. Cram, Science 1983, 219, 1177–
1187.
1924
www.eurjoc.org
© 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2012, 1920–1925